Rubella overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 38: Line 38:
[[Rubella]] infection must be differentiated from diseases presenting with features of [[Rash|skin rash]], [[fever]] and [[lymphadenopathy]] such as [[measles]], [[coxsackievirus]] infection and [[infectious mononucleosis]].
[[Rubella]] infection must be differentiated from diseases presenting with features of [[Rash|skin rash]], [[fever]] and [[lymphadenopathy]] such as [[measles]], [[coxsackievirus]] infection and [[infectious mononucleosis]].
==Epidemiology and Demographics==
==Epidemiology and Demographics==
In the United States, [[endemic]] [[rubella virus]] transmission has been eliminated since 2001. From 2004 to 2013, 10 cases of [[rubella]] infection was diagnosed in the immigrants.
In the United States, [[endemic]] [[rubella virus]] transmission has been eliminated since 2001. From 2004 to 2013, 10 cases of [[rubella]] infection were diagnosed in the immigrants.
 
==Risk Factors==
==Risk Factors==
The [[Risk factor|risk factors]] predisposing for [[rubella]] infection include: contact with infected patient and not receiving [[Vaccination|immunization]] according to the standard schedule.
The [[Risk factor|risk factors]] predisposing for [[rubella]] infection include: contact with infected patient and not receiving [[Vaccination|immunization]] according to the standard schedule.

Revision as of 15:31, 9 May 2017

Rubella Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Rubella from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Case Studies

Case #1

Rubella overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rubella overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rubella overview

CDC on Rubella overview

Rubella overview in the news

Blogs on Rubella overview

Directions to Hospitals Treating Rubella

Risk calculators and risk factors for Rubella overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms: German measles; 3 day measles

Overview

Rubella is a common childhood infection usually with minimal systemic upset although transient arthropathy may occur in adults. Serious complications are very rare. If it were not for the effects of transplacental infection on the developing fetus, rubella is a relatively trivial infection.

Historical Perspective

The clinical picture resembling rubella was described for the first time in 1814 and its role in causing congenital anomalies was identified in 1942. The virus was isolated for the first time in 1962 by two independent groups in tissue culture.

Pathophysiology

The pathophysiology of rubella is not completely understood. Viral replication in the respiratory epithelium occurs following transmission of the virus via contact with droplet secretions from an infected person. Viremia subsequently ensues, with the onset of the rubella rash occurring at the peak of viremia.

Causes

The disease is caused by rubella virus, a togavirus that is enveloped and has a single-stranded RNA genome.[1] The virus is transmitted by the respiratory route and replicates in the nasopharynx and lymph nodes. The virus is found in the blood 5 to 7 days after infection and spreads throughout the body. It is capable of crossing the placenta and infecting the fetus.[2]

Differentiating Rubella from other Diseases

Rubella infection must be differentiated from diseases presenting with features of skin rash, fever and lymphadenopathy such as measles, coxsackievirus infection and infectious mononucleosis.

Epidemiology and Demographics

In the United States, endemic rubella virus transmission has been eliminated since 2001. From 2004 to 2013, 10 cases of rubella infection were diagnosed in the immigrants.

Risk Factors

The risk factors predisposing for rubella infection include: contact with infected patient and not receiving immunization according to the standard schedule.

Screening

There are no standard screening test recommended for rubella infection, however pregnant women with suspected rubella infection must be investigated to confirm the diagnosis to prevent fetal anomalies.

Natural History and Complications

Rubella is transmitted by direct contact and presents with a fever, rash and lymphadenopathy. It is usually a self limiting infection and resolves without any complications. Few patients might develop complications such as arthritis which needs symptomatic treatment. The prognosis is good in adults with complete resolution of symptoms in a week.

Diagnosis

History and Symptoms

Patients with rubella infection present with a fever, skin rash and cervical lymphadenopathy. Malaise and anorexia precede the development of fever and rash.

Physical Examination

Rubella infection in adults presents with low grade fever and a maculopapular rash starting on the face and spreads caudally. Cervical lymphadenopathy is present in majority of the patients.

Laboratory Diagnosis

All patients with suspected rubella infection must be investigated further to confirm the diagnosis. Serological tests to look for the presence of rubella specific IgG antibodies and IgG avidity and RT-PCR should be done to confirm the diagnosis.

Treatment

Medical Therapy

There is no specific antiviral therapy for rubella infection. Symptomatic therapy and reporting the infection to local disease control agencies is recommended.

Surgical Therapy

Surgical intervention is not recommended for the management of rubella infection.

Prevention

Primary Prevention

Rubella infections are prevented by active immunization programs using live, disabled virus vaccines. Two live attenuated virus vaccines, RA 27/3 and Cendehill strains, are effective in the prevention of adult disease

Secondary Prevention

All the patients with confirmed rubella infection must be vaccinated. Pregnant women should be vaccinated after delivery of the baby.[3]

References

  1. Frey TK (1994). "Molecular biology of rubella virus". Adv. Virus Res. 44: 69–160. PMID 7817880.
  2. Edlich RF, Winters KL, Long WB, Gubler KD (2005). "Rubella and congenital rubella (German measles)". J Long Term Eff Med Implants. 15 (3): 319–28. PMID 16022642.
  3. Fleet WF, Vaughn W, Lefkowitz LB, Schaffner W, Federspiel CF (1975). "Gestational exposure to rubella vaccinees: a population surveillance study". Am J Epidemiol. 101 (3): 220–30. PMID 1115060.

Template:WH Template:WS